CanniMed Therapeutics Stock Price, News & Analysis (TSE:CMED)

C$19.88 -0.12 (-0.60 %)
(As of 12/14/2017 04:00 PM ET)
Previous CloseC$20.00
Today's RangeC$19.60 - C$20.05
52-Week RangeC$7.32 - C$21.90
Volume70,194 shs
Average Volume87,542 shs
Market CapitalizationC$472.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About CanniMed Therapeutics (TSE:CMED)

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers. Its vaporizers include Arizer Air vaporizer and Volcano Medic vaporizer. Its vaporizer parts and accessories include ARIZER AIR All Glass Tube (no mouthpiece), ARIZER AIR Charger/Power Adapter, ARIZER AIR Dual Battery Charger, ARIZER AIR Glass Tube with black mouthpiece, ARIZER AIR Replacement Battery, Volcano Medic Air Filter Cap and Volcano Medic Air Filter Set.

Receive CMED News and Ratings via Email

Sign-up to receive the latest news and ratings for CMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryCannabis
SectorN/A
SymbolTSE:CMED
CUSIPN/A
WebN/A
Phone+1-306-9751207

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($1.12)
Net IncomeN/A
Net Margins-28.43%
Return on Equity-5.96%
Return on Assets-4.95%

Miscellaneous

EmployeesN/A
Outstanding Shares22,958,000

CanniMed Therapeutics (TSE:CMED) Frequently Asked Questions

What is CanniMed Therapeutics' stock symbol?

CanniMed Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CMED."

Who are some of CanniMed Therapeutics' key competitors?

Who are CanniMed Therapeutics' key executives?

CanniMed Therapeutics' management team includes the folowing people:

  • Donald R. Ching, Independent Chairman of the Board (Age 74)
  • Brent Zettl, President, Chief Executive Officer, Director (Age 54)
  • John L. Knowles, Chief Financial Officer, Corporate Secretary, Director (Age 61)
  • Gulwant Bajwa, Vice President - Business Development and Regulatory Affairs (Age 54)
  • Larry Holbrook, Chief Research Officer (Age 69)
  • Douglas W. Banzet, Independent Director (Age 66)
  • Rob Duguid, Independent Director (Age 52)
  • Marianne Greer Ph.D., Independent Director (Age 63)
  • Richard Hoyt, Independent Director (Age 63)
  • Dwayne Lawrence Lashyn, Independent Director (Age 52)

How do I buy CanniMed Therapeutics stock?

Shares of CanniMed Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is CanniMed Therapeutics' stock price today?

One share of CanniMed Therapeutics stock can currently be purchased for approximately C$19.88.

How big of a company is CanniMed Therapeutics?

CanniMed Therapeutics has a market capitalization of C$472.79 million.

How can I contact CanniMed Therapeutics?

CanniMed Therapeutics' mailing address is 1 Plant Technology Road, Box 19A, Rr#5, SASKATOON, SK S7K 3J8, Canada. The company can be reached via phone at +1-306-9751207.


MarketBeat Community Rating for CanniMed Therapeutics (CMED)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  57
MarketBeat's community ratings are surveys of what our community members think about CanniMed Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CanniMed Therapeutics (TSE:CMED) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for CanniMed Therapeutics (TSE:CMED)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

CanniMed Therapeutics (TSE:CMED) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for CanniMed Therapeutics (TSE:CMED)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

CanniMed Therapeutics (TSE CMED) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for CanniMed Therapeutics (TSE:CMED)

CanniMed Therapeutics (TSE CMED) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2017Larry HolbrookInsiderSell5,000C$10.25C$51,250.00
9/18/2017Larry HolbrookInsiderSell1,000C$9.41C$9,410.00
7/31/2017Larry HolbrookInsiderSell100C$10.05C$1,005.00
7/13/2017Saskworks Venture Fund Inc.InsiderBuy126,500C$8.35C$1,056,275.00
7/7/2017Saskworks Venture Fund Inc.InsiderBuy21,500C$8.14C$175,010.00
6/28/2017Brenton Harold ZettlDirectorBuy7,300C$7.99C$58,327.00
6/27/2017Brenton Harold ZettlDirectorBuy7,300C$7.99C$58,327.00
6/15/2017Brenton Harold ZettlDirectorBuy50,000C$7.91C$395,500.00
(Data available from 1/1/2013 forward)

Headlines

CanniMed Therapeutics (TSE CMED) News Headlines

Source:
DateHeadline
Ontario regulator to hear Aurora, CanniMed cases on Dec. 20Ontario regulator to hear Aurora, CanniMed cases on Dec. 20
finance.yahoo.com - December 13 at 5:59 PM
Aurora Cannabis wins rights for licensing talks with CannaRoyaltyAurora Cannabis wins rights for licensing talks with CannaRoyalty
finance.yahoo.com - December 13 at 9:14 AM
CanniMed asks Canadian regulators to intervene in hostile Aurora bidCanniMed asks Canadian regulators to intervene in hostile Aurora bid
www.reuters.com - December 12 at 6:20 PM
Canadian regulator schedules hearing on CanniMed-Aurora takeover battleCanadian regulator schedules hearing on CanniMed-Aurora takeover battle
finance.yahoo.com - December 12 at 6:20 PM
PRESS DIGEST-Canada-Dec 12PRESS DIGEST-Canada-Dec 12
finance.yahoo.com - December 12 at 9:25 AM
CanniMed Commences Legal Action against the Aurora Hostile Bid; Files Proxy and Directors Circulars; Urges ... - Business Wire (press release)CanniMed Commences Legal Action against the Aurora Hostile Bid; Files Proxy and Directors' Circulars; Urges ... - Business Wire (press release)
www.businesswire.com - December 11 at 9:40 AM
CanniMed Commences Legal Action against the Aurora Hostile Bid; Files Proxy and Directors’ Circulars; Urges Shareholders to Vote Their Green Proxy in Favour of the Newstrike Acquisition, and to Take No Action to Reject Aurora’s Hostile BidCanniMed Commences Legal Action against the Aurora Hostile Bid; Files Proxy and Directors’ Circulars; Urges Shareholders to Vote Their Green Proxy in Favour of the Newstrike Acquisition, and to Take No Action to Reject Aurora’s Hostile Bid
finance.yahoo.com - December 11 at 9:40 AM
Actions Versus Words: Aurora CEO’s Actions Reveal That Aurora Stock is Inflated; Insiders Sell $17 Million in Stock During Their Hostile Take-over Bid for CanniMed and During a FinancingActions Versus Words: Aurora CEO’s Actions Reveal That Aurora Stock is Inflated; Insiders Sell $17 Million in Stock During Their Hostile Take-over Bid for CanniMed and During a Financing
finance.yahoo.com - November 30 at 5:46 PM
MEDIA ADVISORY: CanniMed Therapeutics Inc. and Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) Announce Webcast and Conference Call to Discuss Plans for Creating a ...MEDIA ADVISORY: CanniMed Therapeutics Inc. and Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) Announce Webcast and Conference Call to Discuss Plans for Creating a ...
www.businesswire.com - November 20 at 6:22 PM
CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) to Create a Premier Global Cannabis CompanyCanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) to Create a Premier Global Cannabis Company
www.businesswire.com - November 17 at 9:33 PM
CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. - TSX-V: HIP) to Create a Premier Global Cannabis CompanyCanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. - TSX-V: HIP) to Create a Premier Global Cannabis Company
finance.yahoo.com - November 17 at 9:33 PM
Update: TSX Posts First Gain of the Week, Rising 56 Points, Boosted by Financial Issues - NasdaqUpdate: TSX Posts First Gain of the Week, Rising 56 Points, Boosted by Financial Issues - Nasdaq
www.nasdaq.com - November 17 at 11:08 AM
CanniMed Acknowledges Aurora Press Release and Announces Exclusivity Agreement and Intention to Acquire Newstrike Resources Ltd.CanniMed Acknowledges Aurora Press Release and Announces Exclusivity Agreement and Intention to Acquire Newstrike Resources Ltd.
www.businesswire.com - November 16 at 12:54 PM
Aurora Cannabis Submits Proposal to CanniMed Therapeutics BoardAurora Cannabis Submits Proposal to CanniMed Therapeutics Board
finance.yahoo.com - November 14 at 10:55 PM
CanniMed Therapeutics Inc. Receives License from Health Canada to Produce Medical Cannabis CapsulesCanniMed Therapeutics Inc. Receives License from Health Canada to Produce Medical Cannabis Capsules
finance.yahoo.com - October 16 at 6:04 PM
CanniMed Therapeutics Inc (CMED) Insider Larry Holbrook Sells 5,000 SharesCanniMed Therapeutics Inc (CMED) Insider Larry Holbrook Sells 5,000 Shares
www.americanbankingnews.com - October 5 at 8:08 PM
CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : October 3, 2017CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : October 3, 2017
finance.yahoo.com - October 3 at 5:08 PM
CanniMed Therapeutics, Inc. – Value Analysis (TORONTO:CMED) : September 19, 2017CanniMed Therapeutics, Inc. – Value Analysis (TORONTO:CMED) : September 19, 2017
finance.yahoo.com - September 19 at 10:24 PM
CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : September 18, 2017CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : September 18, 2017
finance.yahoo.com - September 18 at 5:19 PM
CanniMed Therapeutics Inc. Adds to Executive Leadership Team - Business Wire (press release)CanniMed Therapeutics Inc. Adds to Executive Leadership Team - Business Wire (press release)
www.businesswire.com - September 14 at 11:06 PM
CanniMed Therapeutics Inc. Adds to Executive Leadership TeamCanniMed Therapeutics Inc. Adds to Executive Leadership Team
finance.yahoo.com - September 14 at 6:05 PM
CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017
www.businesswire.com - September 11 at 6:00 PM
CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date - Business Wire (press release)CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date - Business Wire (press release)
www.businesswire.com - September 7 at 3:27 AM
CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release DateCanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date
finance.yahoo.com - September 5 at 6:53 PM
CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CMED-CA : August 25, 2017CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CMED-CA : August 25, 2017
finance.yahoo.com - August 25 at 7:05 PM
CanniMed Therapeutics, Inc. – Value Analysis (TORONTO:CMED) : July 31, 2017CanniMed Therapeutics, Inc. – Value Analysis (TORONTO:CMED) : July 31, 2017
finance.yahoo.com - July 31 at 10:13 PM
Saskworks Venture Fund Inc. Acquires 126,500 Shares of CanniMed Therapeutics Inc (TSE:CMED) StockSaskworks Venture Fund Inc. Acquires 126,500 Shares of CanniMed Therapeutics Inc (TSE:CMED) Stock
www.americanbankingnews.com - July 18 at 7:25 PM
CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : July 14, 2017CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : July 14, 2017
finance.yahoo.com - July 14 at 7:19 PM
CanniMed Therapeutics Inc (TSE:CMED) Insider Purchases C$175,010.00 in StockCanniMed Therapeutics Inc (TSE:CMED) Insider Purchases C$175,010.00 in Stock
www.americanbankingnews.com - July 13 at 5:06 PM

SEC Filings

CanniMed Therapeutics (TSE:CMED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

CanniMed Therapeutics (TSE CMED) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.